Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Aldington

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Current Opinion in Allergy and Clinical Immunology|January 16, 2007
Magnesium in the treatment of asthmaRichard Beasley, Sarah Aldington
Thorax|May 1, 2007
Asthma exacerbations. 5: assessment and management of severe asthma in adults in hospitalSarah Aldington, Richard Beasley
Thorax|October 3, 2007
Is it time to change the approach to oxygen therapy in the breathless patient?Richard Beasley, Sarah Aldington, Geoffrey Robinson
The New Zealand Medical Journal|July 25, 2006
Improving the use and interpretation of diagnostic tests in pulmonary embolismSarah Aldington, Geoffrey Robinson, Richard Beasley
The New Zealand Medical Journal|April 22, 2005
Lung cancer in Maori: a neglected priorityMatire Harwood, Sarah Aldington, Richard Beasley
The New Zealand Medical Journal|November 29, 2005
Increased risk of cardiovascular events with parecoxib/valdecoxib: a systematic review and meta-analysisSarah Aldington, Philippa Shirtcliffe, Mark Weatherall, et al.
Respirology (Carlton, Vic.)|August 19, 2006
Duration of action of the salmeterol/fluticasone combination inhaler administered in the evening: a randomized controlled trial in childhood asthmaSarah Aldington, Mathew Williams, Mark Weatherall, et al.
The New Zealand Medical Journal|June 7, 2005
PHARMAC and tobacco control in New Zealand: government policy 'up in smoke'Shaun Holt, Matire Harwood, Sarah Aldington, et al.
The New Zealand Medical Journal|October 15, 2005
Systematic review and meta-analysis of the risk of major cardiovascular events with etoricoxib therapySarah Aldington, Philippa Shirtcliffe, Mark Weatherall, et al.
Journal of the Royal Society of Medicine|June 2, 2006
Inconsistencies in cardiovascular data from COX-2 inhibitor trials--is it a class effect?Mark Weatherall, Sarah Aldington, Brent Caldwell, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Current Opinion in Allergy and Clinical Immunology|January 16, 2007
Magnesium in the treatment of asthmaRichard Beasley, Sarah Aldington
Thorax|May 1, 2007
Asthma exacerbations. 5: assessment and management of severe asthma in adults in hospitalSarah Aldington, Richard Beasley
Thorax|October 3, 2007
Is it time to change the approach to oxygen therapy in the breathless patient?Richard Beasley, Sarah Aldington, Geoffrey Robinson
The New Zealand Medical Journal|July 25, 2006
Improving the use and interpretation of diagnostic tests in pulmonary embolismSarah Aldington, Geoffrey Robinson, Richard Beasley
The New Zealand Medical Journal|April 22, 2005
Lung cancer in Maori: a neglected priorityMatire Harwood, Sarah Aldington, Richard Beasley
The New Zealand Medical Journal|November 29, 2005
Increased risk of cardiovascular events with parecoxib/valdecoxib: a systematic review and meta-analysisSarah Aldington, Philippa Shirtcliffe, Mark Weatherall, et al.
Respirology (Carlton, Vic.)|August 19, 2006
Duration of action of the salmeterol/fluticasone combination inhaler administered in the evening: a randomized controlled trial in childhood asthmaSarah Aldington, Mathew Williams, Mark Weatherall, et al.
The New Zealand Medical Journal|June 7, 2005
PHARMAC and tobacco control in New Zealand: government policy 'up in smoke'Shaun Holt, Matire Harwood, Sarah Aldington, et al.
The New Zealand Medical Journal|October 15, 2005
Systematic review and meta-analysis of the risk of major cardiovascular events with etoricoxib therapySarah Aldington, Philippa Shirtcliffe, Mark Weatherall, et al.
Journal of the Royal Society of Medicine|June 2, 2006
Inconsistencies in cardiovascular data from COX-2 inhibitor trials--is it a class effect?Mark Weatherall, Sarah Aldington, Brent Caldwell, et al.
Pageof 4